Averion operating losses hit US$857,000
Averion International, the US-based CRO specialising in oncology, cardiovascular disease and medical devices, recorded a net operating loss of US$857,000 for the third quarter ended 30 September.
Mayo Clinic running down clinical trials unit
A competitive market for low-cost clinical studies has driven the non-profit Mayo Clinic in the US to run down its Mayo Clinical Trial Services unit, with the immediate loss of 30 jobs.
UKCRC takes clinical research into the classroom
New classroom resources explaining how illnesses are detected and diagnosed and how medicines are developed and tested have been launched by the UKCRC in support of the science curriculum for 11 to 16 year-olds.
|
 |
Wyeth denies protocol breach after child dies in Indian vaccine trial
Wyeth has denied breaching the inclusion/exclusion criteria for a paediatric vaccines trial in India that was suspended following the death of one of the children taking part.
PharmaNet expands immunochemistry, cell biology capabilities
PharmaNet, the US-based CRO that has been suffering from project cancellations in its late-stage business, is expanding its immunochemistry, cell biology and bioanalytical laboratories at its subsidiary Taylor Technology.
Commission launches website on animal test alternatives
The European Commission has launched a new website to track the progress of alternative test methods that replace, reduce and refine (the 3Rs) the use of animals in research.
|